Activity Summary:
Adult HLH is increasingly recognized as part of a broader hyperinflammatory spectrum, yet early identification and management remain challenging in routine clinical practice. Many adult patients present with nonspecific symptoms that overlap with sepsis, malignancy-associated inflammation, or autoimmune disease, which can delay recognition and treatment.

In this series, Drs. Sarah Nikiforow and Daniella Schwartz explore the full spectrum of adult HLH, from diagnostic suspicion to modern treatment approaches. Through four episodes, this activity aims to strengthen the ability to recognize HLH across diverse clinical settings, integrate biomarkers and prognostic indicators into clinical decision-making, and apply adult-specific management strategies, including emerging therapeutic options.

Activity Summary:
To further expand knowledge from the What's New Doc? From Data to Decisions: Advancing IPF Care in 2026 presented by Dr. Steven Nathan, HCPs can access downloadable resources designed to reinforce and enhance information that can be utilized directly in clinical settings or for further study and reference.

Available Resources:

Clinical Snippet Highlights
Concise, one-page summaries of key IPF studies featured in this activity, offering quick, actionable insights to support day-to-day clinical decision-making.

Downloadable Slides
Downloadable PDF of presentation slides, including data visuals, algorithms, and expert insights - ideal for review, teaching, or clinical discussions.

Expert Commentary Transcript
A downloadable transcript of the podcast/video for learners who prefer text-based review or need an offline resource.

These resources are not designated for continuing education credit. This is in no way a reflection of the integrity or quality of the content.

Activity Summary:
To further expand knowledge from the Relapsed/Refractory Multiple Myeloma in Real Time: Practical Insights for the First Relapse, presented by Drs. Ajai Chari and Sagar Lonial, HCPs can access a variety of downloadable resources designed to reinforce and enhance information that can be utilized directly in clinical settings or for further study and reference.

Clinical Slide Kit
Downloadable PDF of presentation slides, including data visuals, algorithms, and expert insights - ideal for review, teaching, or clinical discussions.

Expert Commentary Transcripts
A downloadable transcript of the podcast/video for learners who prefer text-based review or need an offline resource.

Reference and Resources
Direct access to featured studies, abstracts, and other kit materials cited in the program.

This activity is not designated for continuing education credit. This is in no way a reflection of the integrity or quality of the content.

Activity Summary:
Advances in idiopathic pulmonary fibrosis (IPF) research continue to provide new insights into disease biology, treatment strategies, and the evolving evidence landscape. Yet, translating emerging data into clinical practice remains a challenge for many healthcare professionals.

In this podcast episode, Dr. Steven Nathan discusses the latest clinical trial findings, real-world evidence, and scientific developments shaping the current understanding of IPF. Through expert analysis and practical discussion, he explores the implications of these advances for disease management, treatment decision-making, and the future of IPF care in 2026.

Activity Summary:
Recent advances in idiopathic pulmonary fibrosis (IPF) continue to expand the evidence base, offering important insights into disease biology, therapeutic strategies, and ongoing research. However, clinicians often face challenges in interpreting and applying these insights within the context of evolving IPF care.

In this What's New Doc video, Dr. Steven Nathan reviews the latest clinical trial findings, real-world evidence, and scientific advances shaping the evolving understanding of IPF. By translating emerging data into practical clinical insights, he discusses their impact on disease management, treatment decisions, and the future direction of IPF care in 2026.

Activity Summary:
Continue exploring a collection of downloadable resources designed to support learning and clinical application from our recent activity, Conversations in HIV: Fulfilling Individual Choices to Optimize PrEP Uptake-Persistence.

Available Resources:

Downloadable Slides
Review presentation slides with key data, visuals, and clinical insights.

Podcast Transcript
Download the transcript for convenient text-based review anytime.

These resources are not designated for continuing education credit. This is in no way a reflection of the integrity or quality of the content.

Activity Summary:
Managing relapsed/refractory multiple myeloma (RRMM), particularly at first relapse, requires timely, evidence-based decisions in an increasingly complex treatment landscape. As therapeutic options continue to expand and clinical guidance evolves, healthcare professionals must navigate challenges related to risk stratification, treatment selection, sequencing strategies, and the integration of emerging immunotherapies into practice.

Clinicians may also face uncertainty in distinguishing mechanisms of action, managing immune-related toxicities, and selecting appropriate therapies in the context of treatment resistance. Additionally, real-world barriers such as staffing shortages, infusion capacity constraints, and workflow demands can complicate the implementation of optimal care. This podcast series features expert-led conversations that deliver practical insights and real-world strategies to support confident, guideline-informed decision-making in the management of RRMM.

Activity Summary:
This expert-led roundtable explores HIV prevention through the lens of real patient cases. They examine diverse scenarios, highlighting challenges and successes in implementing prevention methods such as pre-exposure prophylaxis (PrEP), safer sex practices, and regular testing.

Through in-depth discussion of these cases, the group identifies barriers to prevention, cultural and social factors influencing patient behavior, and effective communication strategies. These sessions aim to foster practical insights and improve patient-centered approaches to reduce new HIV infections in diverse populations.

Join us to engage in meaningful dialogue and translate case-based learning into impactful prevention efforts.

Activity Summary:
Relapsed/refractory multiple myeloma (RRMM) remains a complex and rapidly evolving disease state, particularly at first relapse, when timely, evidence-based decisions regarding risk stratification, treatment selection, and sequencing are essential. Healthcare professionals often face challenges keeping pace with expanding therapeutic options, emerging immunotherapies, and evolving clinical guidelines.

Many clinicians report uncertainty in differentiating mechanisms of action, managing immune-related toxicities, and optimizing treatment sequencing in the setting of emerging resistance. In addition, community and mixed-practice settings may encounter practical barriers, including staffing constraints, infusion capacity limitations, and workflow integration challenges. This mini-module series features expert-led discussions focused on practical implementation strategies to support confident, guideline-aligned decision-making and effective real-world application in RRMM care.

Activity Summary:
This expert-led roundtable explores HIV prevention through the lens of real patient cases. They examine diverse scenarios, highlighting challenges and successes in implementing prevention methods such as pre-exposure prophylaxis (PrEP), safer sex practices, and regular testing.

Through in-depth discussion of these cases, the group identifies barriers to prevention, cultural and social factors influencing patient behavior, and effective communication strategies. These sessions aim to foster practical insights and improve patient-centered approaches to reduce new HIV infections in diverse populations.

Join us to engage in meaningful dialogue and translate case-based learning into impactful prevention efforts.

Activity Summary:
Continue exploring a collection of downloadable resources designed to support learning and clinical application from our recent activity, From Refractory to Resolved: Rethinking Uncontrolled Gout in 2026 with Dr. Robert Terkeltaub.

Available Resources:

Downloadable Slides
Review presentation slides with key data, visuals, and clinical insights.

Podcast Transcript
Download the transcript for convenient text-based review anytime.

References & Resources
A list of key studies, abstracts, and materials featured in the activity.

This activity is not designated for continuing education credit. This is in no way a reflection of the integrity or quality of the content.

Activity Summary:
Managing uncontrolled gout isn’t always straightforward—especially when flares persist, comorbidities complicate care, or standard therapies fall short. As our understanding of gout expands beyond just elevated uric acid, clinicians are being asked to think differently, integrating immune pathways, real-world evidence, and emerging treatments into everyday practice.

From Refractory to Resolved: Rethinking Uncontrolled Gout in 2026, this CME-accredited podcast explores how to approach these complex cases with greater clarity and confidence. Featuring expert insights and the latest clinical evidence, each episode dives into practical strategies across the continuum of gout care.

Listeners will hear discussions on advances in uricase-based therapies, selective URAT1 inhibitors, and inflammation-targeted treatments, along with key considerations around safety, sequencing, and collaborative care. Through real-world examples and focused conversations, this series equips clinicians with actionable tools to personalize treatment, address therapeutic challenges, and improve long-term outcomes for patients living with uncontrolled gout.

Activity Summary:
To further build on the insights presented in the Clinical Clips® from EASL Congress 2026: Key Breakthroughs in the Treatment of PBC by Dr. Kris Kowdley, HCPs can access a range of downloadable resources designed to reinforce key concepts and support practical application in clinical care.

Available Resources:

Downloadable Slide Deck (PDF)
Downloadable version of the presentation slides used by the faculty, including data visuals, figures, and key discussion points.

Expert Commentary Transcript
A transcript of the podcast version of the program, reflecting the expert discussion and interpretation of EASL 2026 data.

This activity is not designated for continuing education credit. This is in no way a reflection of the integrity or quality of the content.

Activity Summary:
These podcast episodes explore the rapidly evolving treatment landscape of Primary Biliary Cholangitis, highlighting recent therapeutic advances and reviews emerging clinical evidence on promising investigational therapies.

Designed for healthcare professionals, these episodes provides expert commentary on the latest cutting-edge data presented at EASL Congress 2026. Through an engaging podcast format, listeners will gain practical insights into how new evidence can inform personalized treatment strategies, support improved patient outcomes, and enhance the overall quality of care for people living with PBC.

Activity Summary:
Managing uncontrolled gout can be challenging, especially when patients continue to flare, struggle with comorbidities, or fail to respond as expected to standard therapy. As the understanding of gout evolves beyond hyperuricemia alone, clinicians are increasingly called upon to integrate immune mechanisms, real-world evidence, and new treatment options into everyday decision-making. Staying current requires not only awareness of emerging data, but also clarity on how to apply it in complex, real-world patients.

From Refractory to Resolved: Rethinking Uncontrolled Gout in 2026 is a CME-accredited educational program designed to help clinicians navigate these challenges with confidence. This program brings together expert perspectives, recent clinical evidence, and practical insights across the continuum of gout care. Learners will explore advances in uricase-based therapies, selective URAT1 inhibitors, and inflammation-targeted approaches, while also addressing safety, sequencing, and multidisciplinary coordination. Through focused discussion and clinically relevant examples, participants will gain actionable strategies to personalize care, overcome treatment inertia, and improve long-term management for patients living with uncontrolled gout.

Activity Summary:
These videos provide a concise overview of the latest clinical developments in Primary Biliary Cholangitis presented at EASL Congress 2026. Expert faculty discuss emerging evidence that is shaping the evolving treatment landscape and what these updates may mean for clinical practice.

Watch to gain practical insights into applying the newest data to personalized patient management, with the goal of improving outcomes and advancing the quality of care for individuals living with PBC.

Activity Summary:
To further expand knowledge from the Clinical Clips® in PAH: Conference Highlights, presented by Dr. Vallerie McLaughlin, HCPs can access a variety of downloadable resources designed to reinforce and enhance information that can be utilized directly in clinical settings or for further study and reference.

Clinical Summary Resource
Concise, one-page summary highlighting the most clinically relevant PAH studies and late-breaking presentations discussed in the Clinical Clip.

Downloadable Slide Kit
Downloadable PDF of presentation slides, including data visuals, algorithms, and expert insights - ideal for review, teaching, or clinical discussions.

Expert Commentary Transcript
A downloadable transcript of the podcast/video for learners who prefer text-based review or need an offline resource.

This activity is not designated for continuing education credit. This is in no way a reflection of the integrity or quality of the content.

Activity Summary:
To further expand knowledge from Echo's, Algorithms, and the Art of ILD-PH Detection presented by Dr. Steven Nathan, HCPs can access downloadable resources designed to reinforce and enhance information that can be utilized directly in clinical settings or for further study and reference.

Available Resources:

Downloadable Slides
Downloadable PDF presentation slides, including data, visuals, algorithms, and expert insights - ideal for review, teaching, or clinical discussions.

Expert Commentary Transcript
A downloadable transcript of the video/podcast for learners who prefer text-based review or need an offline resource.

This activity is not designated for continuing education credit. This is in no way a reflection of the integrity or quality of the content.

Activity Summary:
To further expand knowledge from the HCM: Translating Cases into Care presented by Drs. Theodore Abraham and Martin Maron, HCPs can access a variety of downloadable resources designed to reinforce and enhance information that can be utilized directly in clinical settings or for further study and reference.

Downloadable Slide Deck
Downloadable PDF of presentation slides, including data visuals, algorithms, and expert insights - ideal for review, teaching, or clinical discussions.

Expert Commentary Transcript
A downloadable transcript of the podcast/video for learners who prefer text-based review or need an offline resource.

FAQs
A curated set of frequently asked questions addressing key clinical considerations, designed to support informed decision-making.

Reference and Resource Links
Direct access to featured studies, abstracts, and other kit materials cited in the program.

This activity is not designated for continuing education credit. This is in no way a reflection of the integrity or quality of the content.

Activity Summary:
Despite progress in disease identification and treatment strategies, PAH continues to carry considerable morbidity and mortality, highlighting the need for continued optimization of disease management.

Throughout this educational podcast, Dr. Vallerie McLaughlin highlights the latest advances in PAH presented at the International 2026 Conference in Orlando, FL.

Activity Summary:
Despite advances in disease recognition and therapeutic options, PAH remains associated with significant morbidity and mortality, underscoring the importance of optimizing disease management.

Throughout this Clinical Clip, Dr. Vallerie McLaughlin reviews the study design, patient populations, clinical endpoints, efficacy outcomes, and safety findings of selected high-impact research presented in Orlando, Florida May 15-20 at the International 2026 Conference.

Activity Summary:
Hypertrophic Cardiomyopathy (HCM) is often missed or inconsistently treated despite progress in diagnostic tools and treatment options. Clinicians frequently encounter difficulties with early identification, distinguishing HCM from similar conditions, and implementing evolving approaches to risk stratification and therapy.

In this three-part podcast series, Drs. Theodore Abraham and Martin Maron highlight practical approaches for better recognition, diagnosis, and management of HCM.

Activity Summary:
Despite advancements in diagnostics and therapeutics, Hypertrophic Cardiomyopathy (HCM) remains underdiagnosed and inconsistently managed across clinical settings. Clinicians often struggle to identify early signs of HCM, differentiate it from similar cardiac conditions, and apply evolving risk stratification tools and treatment strategies. Traditional therapies provide limited symptom relief and do not address the underlying pathophysiology, while the integration of newer disease-modifying agents such as Cardiac Myosin Inhibitors (CMIs) is still evolving in practice.

During this video series, Drs. Theodore Abraham and Martin Maron address these challenges aiming to improve the recognition, diagnosis, and management of HCM.

Activity Summary:
Pulmonary hypertension (PH) remains a serious and often underrecognized complication in patients with interstitial lung disease (ILD), significantly contributing to increased morbidity, mortality, and overall healthcare burden. Because of the clinical overlap between fibrotic lung disease and PH, early signs are frequently missed, leading to delays in diagnosis and limited opportunities for timely intervention. Evolving definitions and diagnostic criteria for PH further highlight the need to refine and update current screening approaches—especially for patients with early or borderline disease.

In this expert-led podcast, Dr. Nathan shares practical insights on recognizing early indicators of PH in the setting of ILD, interpreting key diagnostic findings, and applying effective risk stratification strategies. The discussion focuses on improving early detection and optimizing management to ultimately enhance outcomes for this high-risk patient population.